BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 11722650)

  • 1. Interleukin-12 stimulation of lymphoproliferative responses in Trypanosoma cruzi infection.
    Galvão da Silva AP; de Almeida Abrahamsohn I
    Immunology; 2001 Nov; 104(3):349-54. PubMed ID: 11722650
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trypanosoma cruzi: maintenance of parasite-specific T cell responses in lymph nodes during the acute phase of the infection.
    Curotto de Lafaille MA; Barbosa de Oliveira LC; Lima GC; Abrahamsohn IA
    Exp Parasitol; 1990 Feb; 70(2):164-74. PubMed ID: 2105229
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytokine and nitric oxide regulation of the immunosuppression in Trypanosoma cruzi infection.
    Abrahamsohn IA; Coffman RL
    J Immunol; 1995 Oct; 155(8):3955-63. PubMed ID: 7561103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antigen-specific Il-4- and IL-10-secreting CD4+ lymphocytes increase in vivo susceptibility to Trypanosoma cruzi infection.
    Barbosa de Oliveira LC; Curotto de Lafaille MA; Collet de Araujo Lima GM; de Almeida Abrahamsohn I
    Cell Immunol; 1996 May; 170(1):41-53. PubMed ID: 8660798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential control of IFN-gamma and IL-2 production during Trypanosoma cruzi infection.
    Nabors GS; Tarleton RL
    J Immunol; 1991 May; 146(10):3591-8. PubMed ID: 1902857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resistant mice lacking interleukin-12 become susceptible to Trypanosoma cruzi infection but fail to mount a T helper type 2 response.
    Galvão Da Silva AP; Jacysyn JF; De Almeida Abrahamsohn I
    Immunology; 2003 Feb; 108(2):230-7. PubMed ID: 12562332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kinetic analysis of antigen-specific immune responses in resistant and susceptible mice during infection with Trypanosoma cruzi.
    Hoft DF; Lynch RG; Kirchhoff LV
    J Immunol; 1993 Dec; 151(12):7038-47. PubMed ID: 8258708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early IFN-gamma production is related to the presence of interleukin (IL)-18 and the absence of IL-13 in experimental Trypanosoma cruzi infections.
    Antúnez MI; Cardoni RL
    Immunol Lett; 2001 Dec; 79(3):189-96. PubMed ID: 11600197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trypanosoma cruzi: IL-10, TNF, IFN-gamma, and IL-12 regulate innate and acquired immunity to infection.
    Abrahamsohn IA; Coffman RL
    Exp Parasitol; 1996 Nov; 84(2):231-44. PubMed ID: 8932773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of interleukin-4 deprivation and treatment on resistance to Trypanosoma cruzi.
    Abrahamsohn IA; da Silva AP; Coffman RL
    Infect Immun; 2000 Apr; 68(4):1975-9. PubMed ID: 10722591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of Trypanosoma cruzi-specific immune responses by a protein produced by T. cruzi in the course of Chagas' disease.
    Kierszenbaum F; Lopez HM; Sztein MB
    Immunology; 1994 Mar; 81(3):462-7. PubMed ID: 8206517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [TH1 response in the experimental infection with Trypanosoma cruzi].
    Cardoni RL; Antúnez MI; Abrami AA
    Medicina (B Aires); 1999; 59 Suppl 2():84-90. PubMed ID: 10668248
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-12 enhances proliferation of peripheral blood mononuclear cells from Chagas' disease patients to Trypanosoma cruzi antigen.
    de Barros-Mazon S; Guariento ME; Abrahamsohn IA
    Immunol Lett; 1997 Jun; 57(1-3):39-45. PubMed ID: 9232423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endogenous IL-10 and IFN-gamma production controls thymic cell proliferation in mice acutely infected by Trypanosoma cruzi.
    Leite de Moraes MD; Minoprio P; Dy M; Dardenne M; Savino W; Hontebeyrie-Joskowicz M
    Scand J Immunol; 1994 Jan; 39(1):51-8. PubMed ID: 8290893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Trypanosoma cruzi membrane mucin AgC10 inhibits T cell activation and IL-2 transcription through L-selectin.
    Alcaide P; Fresno M
    Int Immunol; 2004 Oct; 16(10):1365-75. PubMed ID: 15314038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostaglandins mediate suppression of lymphocyte proliferation and cytokine synthesis in acute Trypanosoma cruzi infection.
    Pinge-Filho P; Tadokoro CE; Abrahamsohn IA
    Cell Immunol; 1999 Apr; 193(1):90-8. PubMed ID: 10202116
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin 10 and interferon gamma regulation of experimental Trypanosoma cruzi infection.
    Silva JS; Morrissey PJ; Grabstein KH; Mohler KM; Anderson D; Reed SG
    J Exp Med; 1992 Jan; 175(1):169-74. PubMed ID: 1730915
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergism between tumor necrosis factor-alpha and interferon-gamma on macrophage activation for the killing of intracellular Trypanosoma cruzi through a nitric oxide-dependent mechanism.
    Muñoz-Fernández MA; Fernández MA; Fresno M
    Eur J Immunol; 1992 Feb; 22(2):301-7. PubMed ID: 1537373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL-4 reduces resistance of mice to Trypanosoma cruzi infection.
    Hiyama K; Hamano S; Nakamura T; Nomoto K; Tada I
    Parasitol Res; 2001 Apr; 87(4):269-74. PubMed ID: 11355674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. During Trypanosoma cruzi infection CD1d-restricted NK T cells limit parasitemia and augment the antibody response to a glycophosphoinositol-modified surface protein.
    Duthie MS; Wleklinski-Lee M; Smith S; Nakayama T; Taniguchi M; Kahn SJ
    Infect Immun; 2002 Jan; 70(1):36-48. PubMed ID: 11748161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.